BLUJEPA
Live / Registered — Registered (as of 22 Oct 2024)
What this means for you
Registered since 22 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98126258
- Registration number
- 7541051
- Mark type
- Design + words
- Filed
- 10 Aug 2023
- Published for opposition
- 06 Aug 2024
- Registered
- 22 Oct 2024
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of bacterial diseases and infections
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 22 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 06 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2024 — PUBLISHED FOR OPPOSITION
- 17 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Jun 2024 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 01 Apr 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 01 Apr 2024 — LETTER OF SUSPENSION E-MAILED
- 01 Apr 2024 — SUSPENSION LETTER WRITTEN
- 01 Apr 2024 — ASSIGNED TO LIE
- 25 Mar 2024 — ASSIGNED TO EXAMINER
- 09 Nov 2023 — TEAS VOLUNTARY AMENDMENT RECEIVED